Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
recital 3recital 3
In vigore · versione del 31 mar 2024
(3) The approval of the active substance hydrolysed proteins, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 15 April 2025.